Allergy/Asthma News

Researchers found a significant association between type 2 inflammation and asthma and an increased risk for coronary artery disease.

The use of electronic nicotine delivery systems by adults in the last 30 days was associated with earlier ages of asthma onset, suggesting that public health measures should be taken to motivate users to stop, according to a recent study.

A presenter at the American Thoracic Society International Conference reported that exposure to violence was associated with neutrophilic asthma among children and adolescents in Puerto Rico.

Patients who received subcutaneous allergen immunotherapy for house dust mite had a reduced probability of asthma onset and development of asthma from allergic rhinitis over time, according to a recent study.

With allergy season in full swing, primary care providers can expect an increase in patients presenting with rhinitis symptoms.

Alpha-gal syndrome, an allergy to sugar in red meat and animal products, is on the rise in the United States, and the culprit is lone star ticks, an expert said.

X4 Pharmaceuticals has announced that the FDA approved Xolremdi as a treatment for warts, hypogammaglobulinemia, infections and myelokathexis, also known as WHIM, syndrome, a rare and chronic primary immunodeficiency.

Climate change and global warming are causing an increase in the prevalence and severity of environmental allergies and an uptick in other immune-related illnesses, according to a review published in Frontiers in Science.

ARS Pharma recently announced that the FDA will likely rule on a new drug application for the company’s neffy epinephrine nasal spray — designed to treat type 1 allergic reactions such as anaphylaxis — by Oct. 2.

Implementing the recent stronger standard for fine particulate pollution revealed that 131 million Americans breathe unhealthy, polluted air where they live, according to a press release from the American Lung Association.